Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation-Reference-Cited by-同舟云学术

Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation

Published:2002-12 Issue:12 Volume:30 Page:945-951
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Burns LJ,Miller W,Kandaswamy C,DeFor TE,MacMillan ML,van Burik J-A,Weisdorf DJ

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703770.pdf

Reference36 articles.

1. Meyers JD, Flournoy N, Thomas ED . Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis 1986 153: 478 488

2. Miller W, Flynn P, McCullough J et al. Cytomegalovirus infection following bone marrow transplantation: an association with acute graft versus host disease Blood 1986 67: 1162 1167

3. Riddell SR . Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts Sem Resp Infect 1995 10: 199 208

4. Zaia JA, Forman SJ . Cytomegalovirus infection in the bone marrow transplant recipient In: Rubin RH (ed.) Infectious Disease Clinics of North America: Infection in transplantation WB Saunders Co.: Philadelphia and London 1995 pp 879 900

5. Meyers JD, Reed EC, Shepp DH et al. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation New Engl J Med 1988 318: 70 75

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients;Transplantation;2023-12-05

2. High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience;Bone Marrow Transplantation;2023-08-23

3. Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience;Hemato;2023-04-28

4. Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide;Leukemia & Lymphoma;2022-02-20

5. Novel Insights to Enhance Therapeutics With Acyclovir in the Management of Herpes Simplex Encephalitis;Journal of Pharmaceutical Sciences;2021-04